Home › Compare › TGRNF vs BTI

TGRNF vs BTI: Dividend Comparison 2026

TGRNF yields 4.55% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BTI wins by $5.2K in total portfolio value
10 years
TGRNF
TGRNF
● Live price
4.55%
Share price
$0.55
Annual div
$0.03
5Y div CAGR
9.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.5K
Annual income
$1,748.22
Full TGRNF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — TGRNF vs BTI

📍 BTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTGRNFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TGRNF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TGRNF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TGRNF
Annual income on $10K today (after 15% tax)
$386.94/yr
After 10yr DRIP, annual income (after tax)
$1,485.99/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, BTI beats the other by $882.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TGRNF + BTI for your $10,000?

TGRNF: 50%BTI: 50%
100% BTI50/50100% TGRNF
Portfolio after 10yr
$35.1K
Annual income
$2,267.43/yr
Blended yield
6.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

TGRNF
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TGRNF buys
0
BTI buys
0
No recent congressional trades found for TGRNF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTGRNFBTI
Forward yield4.55%5.38% ✓
Annual dividend / share$0.03$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.4%11.3% ✓
Portfolio after 10y$32.5K$37.7K ✓
Annual income after 10y$1,748.22$2,786.64 ✓
Total dividends collected$10.0K$14.3K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TGRNF vs BTI ($10,000, DRIP)

YearTGRNF PortfolioTGRNF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$11,198$498.01$11,299$598.92$101.00 → BTI
2$12,552$570.18$12,794$703.91$242.00 → BTI
3$14,084$653.46$14,518$829.07$434.00 → BTI
4$15,820$749.67$16,513$978.64$693.00 → BTI
5$17,788$860.93$18,827$1,157.84$1.0K → BTI
6$20,023$989.77$21,518$1,373.12$1.5K → BTI
7$22,564$1,139.11$24,657$1,632.46$2.1K → BTI
8$25,456$1,312.45$28,329$1,945.74$2.9K → BTI
9$28,751$1,513.87$32,637$2,325.33$3.9K → BTI
10$32,512$1,748.22$37,708$2,786.64$5.2K → BTI

TGRNF vs BTI: Complete Analysis 2026

TGRNF — Stock

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Full TGRNF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this TGRNF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TGRNF vs SCHDTGRNF vs JEPITGRNF vs OTGRNF vs KOTGRNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.